Cesare Gridelli

Cesare Gridelli, MD, is from December 2001 Chief of Division of Medical Oncology at the “S.G. Moscati” Hospital, Avellino (Italy). Director of Department of Oncology/Hematology at the same institution from December 2003 to February 2017 and from March 2018 to date. He earned his medical degree and residencies in Internal Medicine and then in Medical Oncology at the “Federico II” University of Naples (Italy). Since 1993 Vice-Chief of Division of Medical Oncology B, National Cancer Institute of Naples. Since 2001 Chief of Day Hospital Chemotherapy Unit at the same Institute. His areas of expertise are lung cancer and cancer in the elderly. He is deeply involved in the clinical development of new anticancer targeted therapies and immunotherapy. He is member of several national and international scientific societies. He served as President of the Italian Association of Thoracic Oncology (AIOT) from 2013 to 2017. He is member of Advisory Board of scientific journals and of several expert panels. Dr. Gridelli has been invited as speaker at international conferences and educational activities of oncology societies (ASCO, ESMO etc.). He gave 3 oral presentation on clinical trials and 5 educational talks at the annual ASCO meetings. He received the Awards and Lecture in Geriatric Oncology of the American Society of Medical Oncology (ASCO) in 2021. He is author or co-author of more then 750 papers, of which more then 470 extended papers published on international indexed journals , and several chapters of books. His papers have about 25.000 citations on international indexed journals. Dr. Gridelli has an h-index of 73. On November 2013 the American agency Expertscape (Palo Alto, California) appointed Dr. Gridelli at the first place among the top world experts on lung cancer. The first place has been confirmed by the same American agency on August 2019.